Literature DB >> 26556533

IGF-I and IGFBP-2 Stimulate AMPK Activation and Autophagy, Which Are Required for Osteoblast Differentiation.

Gang Xi1, Clifford J Rosen1, David R Clemmons1.   

Abstract

IGF-I/insulin-like growth factor binding protein 2 (IGFBP-2) coordinately stimulate osteoblast differentiation but the mechanisms by which they function have not been determined. AMP-activated protein kinase (AMPK) is induced during differentiation and AMPK knockout mice have reduced bone mass. IGF-I modulates AMPK in other cell types; therefore, these studies determined whether IGF-I/IGFBP-2 stimulate AMPK activation and the mechanism by which AMPK modulates differentiation. Calvarial osteoblasts and MC-3T3 cells expressed activated AMPK early in differentiation and AMPK inhibitors attenuated differentiation. However, expression of constitutively activated AMPK inhibited differentiation. To resolve this discrepancy we analyzed the time course of AMPK induction. AMPK activation was required early in differentiation (day 3-6) but down-regulation of AMPK after day 9 was also necessary. IGF-I/IGFBP-2 induced AMPK through their respective receptors and blocking-receptor activation blocked AMPK induction. To determine the mechanism by which AMPK functioned we analyzed components of the autophagosome. Activated AMPK stimulated ULK-1 S555 phosphorylation as well as beclin-1 and microtubule-associated protein 1A/1B light-chain phosphatidylethanolamine conjugate (LC3II) induction. Inhibition of AMPK attenuated these changes and direct inhibition of autophagy inhibited differentiation. Conversely, expression of activated AMPK was associated with persistence of these changes beyond day 9 and inhibited differentiation. Blocking AMPK activation after day 9 down-regulated these autophagosome components and rescued differentiation. This allowed induction of mechanistic target of rapamycin and AKT, which suppressed autophagy. The results show that early induction of AMPK in response to IGF-I/IGFBP-2 followed by suppression is required for osteoblast differentiation. AMPK functions through stimulation of autophagy. The findings suggest that these early catabolic changes are important for determining the energy source for osteoblast respiration and down-regulation of these components may be required for induction of glycolysis, which is required during the final anabolic stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26556533      PMCID: PMC4701891          DOI: 10.1210/en.2015-1690

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation.

Authors:  Emel Esen; Jianquan Chen; Courtney M Karner; Adewole L Okunade; Bruce W Patterson; Fanxin Long
Journal:  Cell Metab       Date:  2013-04-25       Impact factor: 27.287

2.  p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche.

Authors:  Kyung Hee Chang; Amitava Sengupta; Ramesh C Nayak; Angeles Duran; Sang Jun Lee; Ronald G Pratt; Ashley M Wellendorf; Sarah E Hill; Marcus Watkins; Daniel Gonzalez-Nieto; Bruce J Aronow; Daniel T Starczynowski; Roberto Civitelli; Maria T Diaz-Meco; Jorge Moscat; Jose A Cancelas
Journal:  Cell Rep       Date:  2014-12-18       Impact factor: 9.423

3.  Insulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle.

Authors:  Rudy J Valentine; Kimberly A Coughlan; Neil B Ruderman; Asish K Saha
Journal:  Arch Biochem Biophys       Date:  2014-08-27       Impact factor: 4.013

Review 4.  Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress.

Authors:  Shi-Bei Wu; Yu-Ting Wu; Tsung-Pu Wu; Yau-Huei Wei
Journal:  Biochim Biophys Acta       Date:  2013-10-27

5.  Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss.

Authors:  Victoria E DeMambro; Phuong T Le; Anyonya R Guntur; David E Maridas; Ernesto Canalis; Kenichi Nagano; Roland Baron; David R Clemmons; Clifford J Rosen
Journal:  Endocrinology       Date:  2015-07-31       Impact factor: 4.736

Review 6.  Autophagosome formation--the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage.

Authors:  Martina Wirth; Justin Joachim; Sharon A Tooze
Journal:  Semin Cancer Biol       Date:  2013-05-29       Impact factor: 15.707

7.  Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation.

Authors:  Fei Liu; Fang Fang; Hebao Yuan; Dongye Yang; Yongqiang Chen; Linford Williams; Steven A Goldstein; Paul H Krebsbach; Jun-Lin Guan
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

8.  IGFBP-2 directly stimulates osteoblast differentiation.

Authors:  Gang Xi; Christine Wai; Victoria DeMambro; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

Review 9.  The ULK1 complex: sensing nutrient signals for autophagy activation.

Authors:  Pui-Mun Wong; Cindy Puente; Ian G Ganley; Xuejun Jiang
Journal:  Autophagy       Date:  2013-01-07       Impact factor: 16.016

10.  FGF7/KGF regulates autophagy in keratinocytes: A novel dual role in the induction of both assembly and turnover of autophagosomes.

Authors:  Francesca Belleudi; Valeria Purpura; Silvia Caputo; Maria Rosaria Torrisi
Journal:  Autophagy       Date:  2014-02-26       Impact factor: 16.016

View more
  33 in total

Review 1.  Mechanisms of marrow adiposity and its implications for skeletal health.

Authors:  Annegreet G Veldhuis-Vlug; Clifford J Rosen
Journal:  Metabolism       Date:  2016-11-27       Impact factor: 8.694

2.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

Review 3.  Energy Metabolism of the Osteoblast: Implications for Osteoporosis.

Authors:  Wen-Chih Lee; Anyonya R Guntur; Fanxin Long; Clifford J Rosen
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 4.  Effect of type 2 diabetes medications on fracture risk.

Authors:  Cristian Guja; Loreta Guja; Rucsandra Dănciulescu Miulescu
Journal:  Ann Transl Med       Date:  2019-10

Review 5.  Bone Cell Bioenergetics and Skeletal Energy Homeostasis.

Authors:  Ryan C Riddle; Thomas L Clemens
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 6.  Autophagy in fate determination of mesenchymal stem cells and bone remodeling.

Authors:  Xiao-Dan Chen; Jia-Li Tan; Yi Feng; Li-Jia Huang; Mei Zhang; Bin Cheng
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

7.  An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth.

Authors:  Tomoya Uchimura; Judith M Hollander; Daisy S Nakamura; Zhiyi Liu; Clifford J Rosen; Irene Georgakoudi; Li Zeng
Journal:  Development       Date:  2017-10-01       Impact factor: 6.868

Review 8.  IGF-1 signaling mediated cell-specific skeletal mechano-transduction.

Authors:  Faming Tian; Yongmei Wang; Daniel D Bikle
Journal:  J Orthop Res       Date:  2017-11-22       Impact factor: 3.494

9.  Osteoblast-like MC3T3-E1 Cells Prefer Glycolysis for ATP Production but Adipocyte-like 3T3-L1 Cells Prefer Oxidative Phosphorylation.

Authors:  Anyonya R Guntur; Akos A Gerencser; Phuong T Le; Victoria E DeMambro; Sheila A Bornstein; Shona A Mookerjee; David E Maridas; David E Clemmons; Martin D Brand; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2018-03-30       Impact factor: 6.741

Review 10.  Energy Metabolism of Osteocytes.

Authors:  Vivin Karthik; Anyonya R Guntur
Journal:  Curr Osteoporos Rep       Date:  2021-06-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.